Why SUDS Outpatient Involves This Service
Harm reduction lowers overdose and infectious risk while preserving engagement and access to evidence-based treatment.
Common Involvement Triggers
Ongoing use, overdose history or risk, treatment ambivalence, injection-related risk, fentanyl exposure, or barriers to conventional treatment entry.
Shared-Care Responsibilities
Clarify naloxone education, medication access, safer-use counseling, medical testing, wound or infectious-disease care, and follow-up ownership.
Handoff Essentials
Communicate the immediate risk, requested harm-reduction support, current medications, relevant medical needs, and patient-centered goals through approved channels.
Continuity and Return Plan
Keep access low-threshold, revisit treatment preferences, document risk-reduction steps, and maintain a clear route back to SUDS follow-up.
Operational Boundary
Confirm current eligibility, capacity, consult names, schedules, contacts, and transfer procedures in approved VA systems.
Publicly Confirmed Sources
These links establish public context; they do not establish current local availability or workflow.